Tech Company Financing Transactions

Sciwind Biosciences Funding Round

IDG Capital Partners, Loyal Valley Capital and Lyfe Capital participated in a $70 million Series C funding round for Sciwind Biosciences. The round was announced on 10/16/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

3001 Bishop Dr. 300
San Ramon, CA 94583
USA

Phone

Undisclosed

Website

www.sciwindbio.com

Email Address

[email protected]

Overview

We are a fast-growing clinical-stage biopharmaceutical company developing a portfolio of therapeutic candidates for metabolic disease. Our goal is to develop first-in-class and best-in-class single-agent and combination treatments to benefit patients with obesity, type 2 diabetes, and non-alcoholic steatohepatitis (NASH).

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Hai Pan

        

Chief Scientific Officer

Xinle Wu

        

President

Weidong Zhong

        

Vice President

Martijn Fenaux

        

Browse more venture capital transactions:

Prev: 10/16/2021: Nexla venture capital transaction
Next: 10/16/2021: AwareHQ.com venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to record every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary